Enanta Pharmaceuticals (NASDAQ:ENTA) Now Covered by JPMorgan Chase & Co.
JPMorgan Chase & Co. started coverage on shares of Enanta Pharmaceuticals (NASDAQ:ENTA – Free Report) in a research note released on Friday, MarketBeat reports. The firm issued an overweight rating and a $17.00 target price on the biotechnology company’s stock. Several other research firms have also recently issued reports on ENTA. Weiss Ratings reaffirmed a […]
15 Nov 18:50 · The Markets Daily